News
LCTX ▼ -10.8% - Lineage Cell Therapeutics, Inc.
LCTX ▼ -10.8% - Lineage Cell Therapeutics, Inc.
$LCTX Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington's Disease
12-NOV-2026 04:03 PM ET
Share this post
More filings for $LCTX
LCTX ▼ -9.9% - Lineage Cell Therapeutics, Inc.Nov 12, 2026LCTX ▲ +1.9% - Lineage Cell Therapeutics, Inc.Sep 8, 2026$LCTX SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $LCTX filing history →💬 Comments
Loading comments…
Leave a comment